Target intelligence / Profile preview

MIR122 host gene (MIR122HG)

Target
MIR122HG
Molecular classification
Long non-coding RNA, microRNA host gene, Other
01

Overview

MIR122 host gene (MIR122HG) is a long non-coding RNA that serves as the primary transcript and host gene for the liver-specific microRNA miR-122-5p[1][5]. MIR122HG undergoes processing to produce miR-122, which is highly abundant in hepatocytes and plays major roles in metabolic homeostasis, antiviral responses, and tumor suppression. Overexpression or knockdown of MIR122HG regulates miR-122 expression and thereby influences liver cell proliferation, immune signaling, and the host response to viral infections such as hepatitis C[1]. MIR122HG itself functions mainly by controlling the availability of miR-122-5p, and is not known to have independent protein-coding or receptor/enzymatic activities. It is not currently considered a direct therapeutic target, although its product (miR-122) is being investigated for clinical applications in liver diseases and viral hepatitis therapy[1][2][5]. The misregulation of MIR122HG or miR-122 is implicated in hepatocellular carcinoma and other liver pathologies[2][3][4].

Other names
lnc-pri-miR-122MIR122HG
02

Mechanism of action

Not directly targeted by drugs; acts by providing the primary transcript for miR-122-5p, which regulates gene expression post-transcriptionally

03

Biological functions

Regulation of microRNA (miR-122-5p) biogenesisNegative regulation of cell proliferationModulation of innate antiviral immunity
04

Disease associations

Cancer (especially hepatocellular carcinoma)Infection (viral infections)
05

Safety considerations

Not directly targeted, but manipulation of MIR122HG or its product (miR-122) could affect liver function, lipid metabolism, cell proliferation, and antiviral responses[1][4]
06

Interacting drugs

None known for MIR122HG (drugs target miR-122, not MIR122HG itself)
07

Biomarkers

Elevated or reduced levels of MIR122HG (via miR-122) may serve as a biomarker for liver injury, cancer, and viral infection but MIR122HG itself is not an established clinical biomarker[2][4][5]

Beyond the preview

Go deeper on MIR122 host gene (MIR122HG).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MIR122 host gene (MIR122HG).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call